Baseline levels of C-reactive protein and prediction of death from cardiovascular disease in patients with inflammatory polyarthritis: A ten-year followup study of a primary care-based inception cohort

Arthritis and Rheumatism

Volumn 52, Issue 8, 2005, Pages 2293-2299

  Goodson, Nicola J ^a   Symmons, Deborah P M ^a   Scott, David G I ^b   Bunn, Diane ^b   Lunt, Mark ^a   Silman, Alan J ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b NORFOLK AND NORWICH UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; RHEUMATOID FACTOR;

ADULT; AGE; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CAUSE OF DEATH; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; FOLLOW UP; HEALTH ASSESSMENT QUESTIONNAIRE; HUMAN; HYPERTENSION; INFLAMMATORY POLYARTHRITIS; INTERVIEW; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIVARIATE ANALYSIS; POLYARTHRITIS; PREDICTION; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUESTIONNAIRE; REGRESSION ANALYSIS; SEX DIFFERENCE; SMOKING; SOCIOECONOMICS; UNITED KINGDOM; VASCULAR DISEASE;

ADULT; AGED; ARTHRITIS; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; OSMOLAR CONCENTRATION; PREDICTIVE VALUE OF TESTS; PRIMARY HEALTH CARE; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RHEUMATOID FACTOR; SEVERITY OF ILLNESS INDEX;

EID: 23644453158     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.21204     Document Type: Article

References (36)

1. Wallberg-Jonsson S, Ohman ML, Dahlqvist SR. Cardiovascular morbidity and mortality in patients with seropositive rheumatoid arthritis in Northern Sweden. J Rheumatol 1997;24:445-51.
2. Del Rincon I, Williams K, Stern MP, Freeman GL, Escalante A. High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors. Arthritis Rheum 2001;44:2737-45.
3. Solomon DH, Karlson EW, Rimm EB, Cannuscio CC, Mandl LA, Manson JE, et al. Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis. Circulation 2003;107: 1303-7.
4. Myllykangas-Luosujarvi R, Aho K, Kautianen H, Isomaki H. Cardiovascular mortality in women with rheumatoid arthritis. J Rheumatol 1995;22:1065-7.
5. Wolfe F, Mitchell DM, Sibley JT, Fries JF, Bloch DA, Williams CA, et al. The mortality of rheumatoid arthritis. Arthritis Rheum 1994;37:481-94.
6. Symmons DP, Jones MA, Scott DL, Prior P. Longterm mortality outcomes in patients with rheumatoid arthritis: early presenters continue to do well. J Rheumatol 1998;25:1072-7.
7. Goodson NJ, Wiles NJ, Lunt M, Barrett EM, Silman AJ, Symmons DP. Mortality in early inflammatory polyarthritis: cardiovascular mortality is increased in seropositive patients. Arthritis Rheum 2002;46:2010-9.
8. Tracy RP. Inflammation markers and coronary heart disease. Curr Opin Lipidol 1999;10:435-41.
9. Koenig W, Sund M, Frohlich M, Fischer HG, Lowel H, Doring A, et al. C-reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA (monitoring trends and determinants in cardiovascular disease) Augsburg study 1984 to 1992. Circulation 1999;99:237-42.
10. Ridker PM, Hennikens CH, Buring JE, Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 2000;342:836-43.
11. Ridker PM, Cushman M, Stampher MJ, Tracy RP, Hennikens CH. Inflammation, aspirin and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 1997;336:973-9.
12. Magadle R, Weiner P, Beckerman M, Berar-Yanay N. C-reactive protein as a marker for active coronary artery disease in patients with chest pain in the emergency room. Clin Cardiol 2002;25: 456-60.
13. Pasceri V, Willerson JT, Yeh ET. Direct proinflammatory effect of C-reactive protein on human endothelial cells. Circulation 2000; 102:2165-8.
14. Zwaka TP, Hombach V, Torzewski J. C-reactive protein mediated low density lipoprotein uptake by macrophages: implications for atherosclerosis [abstract]. Circulation 2001;103:1194-7.
15. Blake GJ, Ridker PM. Novel clinical markers of vascular wall inflammation. Circ Res 2001;89:763-71.
16. Rosenson RS, Koenig W. High-sensitivity C-reactive protein and cardiovascular risk in patients with coronary heart disease. Curr Opin Cardiol 2002;17:325-31.
17. Blake GJ, Ridker PM. C-reactive protein, subclinical atherosclerosis, and risk of cardiovascular events. Arterioscler Thromb Vasc Biol 2002;22:1512-3.
18. Folsom AR, Aleksic N, Catellier D, Juneja HS, Wu KK. C-Reactive protein and incident coronary heart disease in the Atherosclerosis Risk In Communities (ARIC) Study. Am Heart J 2002;144:233-8.
19. Symmons DP, Barrett EM, Bankhead CR, Scott DG, Silman AJ. The incidence of rheumatoid arthritis in the United Kingdom: results from the Norfolk Arthritis Register. Br J Rheumatol 1994;33:735-9.
20. Joint Formulary Committee. British national formulary. 43rd ed. Bath: BMA, The Pharmaceutical Press; 2002.
21. Fries JF, Spitz P, Kraines RG, Holman HR. Measurement of patient outcome in arthritis. Arthritis Rheum 1980;23:137-45.
22. Charlton J, Murphy M. Monitoring health-data sources and methods. In: Charlton J, Murphy M, editors. The health of adult Britain: 1841-1994. London: Stationary Office; 1997. p. 2-16.
23. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries J, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
24. Bukhari M, Lunt M, Harrison BJ, Scott DG, Symmons DP, Silman AJ. Rheumatoid factor is the major predictor of increasing severity of radiographic erosions in rheumatoid arthritis: results from the Norfolk Arthritis Register Study, a large inception cohort. Arthritis Rheum 2002;46:906-12.
25. Benzaquen LR, Yu H, Rifai N. High sensitivity C-reactive protein: an emerging role in cardiovascular risk assessment. Crit Rev Clin Lab Sci 2001;39:459-97.
26. Wolfe F, Pincus T. The level of inflammation in rheumatoid arthritis is determined early and remains stable over the longterm course of the illness. J Rheumatol 2001;28:1817-24.
27. Aman S, Paimela L, Leirisalo-Repo M, Risteli J, Kautiainen H, Helve T, et al. Prediction of disease progression in early rheumatoid arthritis by ICTP, RF and CRP: a comparative 3-year followup study. Rheumatology (Oxford) 2000;39:1009-13.
28. Cannon PJ, Connell PA, Stockley IH, Garner ST, Hampton JR. Prevalence of angina as assessed by a survey of prescriptions for nitrates. Lancet 1988;64:979-81.
29. Saito M, Ishimitsu T, Minami J, Ono H, Ohrui M, Matsuoka H. Relations of plasma high-sensitivity C-reactive protein to traditional cardiovascular risk factors. Atherosclerosis 2003;167:73-9.
30. Rohde LE, Hennekens CH, Ridker PM. Survey of C-reactive protein and cardiovascular risk factors in apparently healthy men. Am J Cardiol 1999;84:1018-22.
31. Visser M, Bouter LM, McQuillan GM, Wener MH, Harris TB. Elevated C-reactive protein levels in overweight and obese adults. J Am Med Assoc 1999;282:2131-5.
32. Hak AE, Stehouwer CD, Bots ML, Polderman KH, Sehalkwijk CG, Westendorp IC, et al. Associations of C-reactive protein with measures of obesity, insulin resistance, and subclinical atherosclerosis in healthy, middle-aged women. Arterioscler Thromb Vasc Biol 1999;8:1986-91.
33. Cotton F, Thiry P, Husain AB, Boeynaems JM. Analyzer transfer of a broad range high-sensitivity C-reactive protein immunoassay. Clin Lab 2001;47:405-9.
34. Wiles N, Symmons DP, Harrison B, Barrett E, Barrett JH, Scott DG, et al. Estimating the incidence of rheumatoid arthritis: trying to hit a moving target? Arthritis Rheum 1999;42:1339-46.
35. Symmons DP, Hazes JM, Silman AJ. Patients with early inflammatory polyarthritis should not be classified as having rheumatoid arthritis. J Rheumatol 2003;30:902-4.
36. Tomai F, Crea F, Gaspardone A, Versaci F, Ghini AS, Chiariello L, et al. Unstable angina and elevated C-reactive protein levels predict enhanced vasoreactivity of the culprit lesion. Circulation 2001;104:1471-6.